IBRX - ImmunityBio, Inc. Common Stock -  [ ]

Ticker Details
ImmunityBio, Inc. Common Stock
IPO Date: July 27, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $5.86B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.25 | 4.44%
Avg Daily Range (30 D): $0.29 | 5.73%
Avg Daily Range (90 D): $0.15 | 4.05%
Institutional Daily Volume
Avg Daily Volume: 4.83M
Avg Daily Volume (30 D): 39.45M
Avg Daily Volume (90 D): 20.19M
Trade Size
Avg Trade Size (Sh.): 252
Avg Trade Size (Sh.) (30 D): 353
Avg Trade Size (Sh.) (90 D): 375
Institutional Trades
Total Institutional Trades: 1,466
Avg Institutional Trade: $1.88M
Avg Institutional Trade (30 D): $1.87M
Avg Institutional Trade (90 D): $1.87M
Avg Institutional Trade Volume: .4M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.98M
Avg Closing Trade (30 D): $4.4M
Avg Closing Trade (90 D): $2.61M
Avg Closing Volume: 406.22K
 
News
Feb 13, 2026 @ 8:32 PM
Top 10 Most Shorted Stocks: CleanSpark, Hims & Her...
Source: Erica Kollmann
Feb 3, 2026 @ 6:00 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: Pomerantz Llp
Feb 2, 2026 @ 7:08 PM
These 10 Stocks Could Be Short Squeeze Targets: Lu...
Source: Erica Kollmann
Jan 30, 2026 @ 7:51 PM
These 10 Stocks Just Had Their Best Or Worst Month...
Source: Piero Cingari
Jan 26, 2026 @ 10:02 PM
Stock Market Today, Jan. 20: ImmunityBio Soars Aga...
Source: Josh Kohn-Lindquist
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-.07 $-.1 $-.15
Diluted EPS $-.07 $-.1 $-.15
Revenue $32.06M $26.43M $16.52M
Gross Profit $31.88M $26.29M $16.46M
Net Income / Loss $-67.27M $-92.57M $-129.67M
Operating Income / Loss $-55.63M $-71.29M $-64.43M
Cost of Revenue $.18M $.14M $.06M
Net Cash Flow $-76.75M $76.92M $-82.76M
PE Ratio